Finally, an “heartening” African development regarding the mutated lineage


Trials of the Novavax vaccine in South Africa have shown an efficacy of 60% against The mutated virus strain, Scattered there very quickly.

This strain has become responsible for more than 90 percent of new cases in South AfricaIt is more contagious than the original virus.

Early results from a British study indicate that the vaccine is approximately 96 percent effective against Corona Virus The original, and 86 percent effective against the mutated strain there, are results, although varied, but were widely welcomed in Pretoria.

The South African Health Association welcomed the results, but called for more research Vaccines Other and obtain more clinical data for the vaccine NovavaxEspecially for people with HIV.

That is, according to the same association, vaccines are often tested on healthy people, which means that a period of 3 to 5 years is required to find out whether the vaccines have any Side effects On people with chronic diseases.

South Africa will receive the first batch of AstraZeneca vaccines from the India Serum Institute, on Monday.

Source link


Please enter your comment!
Please enter your name here